Navigation Links
Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update
Date:2/23/2012

conduct its research, development and commercialization activities; the Company's dependence on its collaboration with Novartis; changes in the Company's business plan or objectives; the ability of the Company to attract and retain qualified personnel; competition in general; and the Company's ability to obtain, maintain and enforce patent and other intellectual property protection for its product candidates and its discoveries. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. These and other risks which may impact management's expectations are described in greater detail under the heading "Risk Factors" in the Company's annual report on Form 10-K for the year ended December 31, 2010, and the quarterly report on Form 10-Q for the quarter ended September 30, 2011, each as filed with the Securities and Exchange Commission (SEC) and in any subsequent periodic or current report that the Company files with the SEC.

All forward-looking statements reflect the Company's estimates only as of the date of this release (unless another date is indicated) and should not be relied upon as reflecting the Company's views, expectations or beliefs at any date subsequent to the date of this release. While Idenix may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so, even if the Company's estimates change.IDENIX PHARMACEUTICALS, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(IN THOUSANDS, EXCEPT PER SHARE DATA)(UNAUDITED)Three Months Ended
December 31,

Years Ended
December 31,2011201020112010Revenues:Collaboration revenue – related party

$  (1,387)$
(135)$  4,328$  6,231Other revenue6552,5702,6233,991Total revenues  

(732)2,4356,95110,222Operati
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
2. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
3. Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
4. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
5. Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients
6. Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
7. Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV
8. Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
9. Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Idenix Announces Data Presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 19, 2014 ... ) has announced the addition of the ... report to their offering.      ... study of chromosomes using molecular biology to ... and chromosomes. It plays a crucial role ...
(Date:9/18/2014)... September 18, 2014 ... ) has announced the addition of the  ...  report to their offering.       ... worldwide markets for Sugar Alcohols in Million ... & Confectionery, Pharmaceuticals, Cosmetics, Oral-Care Products, and ...
(Date:9/18/2014)... , Sept. 18, 2014   MacPractice,s MacPractice ... Edition Complete EHR certification, which designates that the software ... Stage 1 and Stage 2 Meaningful Use measures required ... Reinvestment Act (ARRA).  MacPractice MD MU version 5.0 was ... , an Office of the National Coordinator-Authorized Certification Body ...
Breaking Medicine Technology:Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3Sugar Alcohols - Global Strategic Business Report 201 2Sugar Alcohols - Global Strategic Business Report 201 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 4MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 5
... 2, 2011 Doctors should consider using catheterization as ... in diagnosing children with heart defects, according to a ... (Logo: http://photos.prnewswire.com/prnh/20100222/AHSALOGO ) A catheter is ... and used in procedures such as angiography, in which ...
... Lpath, Inc. (OTCBB: LPTN), the category leader ... President and CEO, will present at RetailInvestorConferences.com.DATE: ... EDTLINK: , www.retailinvestorconferences.com >Click the red "register/ ... interactive online event where investors are invited to ...
Cached Medicine Technology:Catheterization Recommended for Treating Pediatric Heart Conditions 2Catheterization Recommended for Treating Pediatric Heart Conditions 3Lpath, Inc. CEO to Present Live, Online at RetailInvestorConferences.com on May 5th 2Lpath, Inc. CEO to Present Live, Online at RetailInvestorConferences.com on May 5th 3
(Date:9/18/2014)... 2014 Alexandria, VA — The ... 10 more communities have joined the growing ranks of ... accreditation. The decisions bring the number of governmental public ... is the non-profit organization that administers the national public ... the health of the public by advancing the quality ...
(Date:9/18/2014)... THURSDAY, Sept. 18, 2014 (HealthDay News) -- Exposure to ... a new study. Hearing different languages in ... and willing to learn from people who are different ... that children, like adults, are often biased against interacting ... them," said Amanda Woodward, a University of Chicago psychology ...
(Date:9/18/2014)... 2014 (HealthDay News) -- Older people become more physically ... the balance of stress hormones during bereavement changes with ... who are grieving are more likely to have weakened ... "During the difficult weeks and months after loss, we ... most abundant type of white blood cell and as ...
(Date:9/18/2014)... September 18, 2014 "Medical staff need ... while also maintaining the patient's privacy," said one of ... this idea in order to supply caregivers with the ... They created a prototype for The Helper to make ... staff to turn patient onto his or her side. ...
(Date:9/18/2014)... Luis Obispo, CA (PRWEB) September 18, 2014 ... Bootie introduced their newest, patent pending bunion splint to ... As one loyalist, Rosa, wrote: "I was absolutely delighted. It ... I honestly forget I am wearing them. THANK YOU FOR ... recently introduced design by saying, "The hole used to slip ...
Breaking Medicine News(10 mins):Health News:Ten More Communities Reaping Benefits of National Accreditation 2Health News:Ten More Communities Reaping Benefits of National Accreditation 3Health News:Ten More Communities Reaping Benefits of National Accreditation 4Health News:Study: Exposure to Diversity Might Boost Baby's Social Skills 2Health News:Grief Can Weigh on Immune System in Older Folks, Study Says 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3
... release of the first long-range plan for tackling digestive ... each year. , Opportunities and Challenges in Digestive Diseases ... describes the impact of diseases ranging from foodborne infections ... for research over the next 10 years. The report ...
... BOTHELL, Wash., April 2 SCOLR Pharma, Inc. ... of HealthPro BioVentures LLC ("HealthPro"), a life sciences ... financial advisor in connection with the evaluation of ... strategic partners."We are excited about HealthPro joining our ...
... may work better than eating less, study finds , , THURSDAY, ... weight, cutting back on the calories in sugar-sweetened drinks, rather ... who found that cutting back on calories from sugary beverages ... nearly two-and-a-half pounds of lost weight over 18 months. ...
... Health Care has appointed a nationally recognized ... president of cancer services. (Logo: http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b ... Children,s Research Hospital in Memphis, where he served ... domestic affiliates. Prior to that, he was chief ...
... Medical Systems (NYSE: VAR ) announced today that ... noon through 2 p.m. on May 7, 2009 in Boston ... Lafayette. Management presentations will cover financial performance through the ... opportunities in markets for oncology systems, x-ray imaging, and security ...
... Researchers at UT Southwestern Medical Center have shed ... process important information. , Researchers found in a study ... molecules used by nerve cells to communicate with one ... and changes brain-cell circuitry to process important information differently ...
Cached Medicine News:Health News:NIH releases the first research plan to reduce the burden of digestive diseases 2Health News:NIH releases the first research plan to reduce the burden of digestive diseases 3Health News:SCOLR Pharma, Inc. Announces Engagement of HealthPro as Financial Advisor 2Health News:Fewer Sugary Drinks Key to Weight Loss 2Health News:Fewer Sugary Drinks Key to Weight Loss 3Health News:Nationally Recognized Oncologist to Lead Aurora Health Care's Cancer Services 2Health News:Nationally Recognized Oncologist to Lead Aurora Health Care's Cancer Services 3Health News:Varian Medical Systems Schedules Mid-Year Review With Investors in Boston 2Health News:UT Southwestern researchers reveal how the brain processes important information 2
Baby Weitlaner retractor, blunt, 4"....
Bruns (Volkmann) bone curette, with Novotex plastic handle (autoclavable in autoclave up to 143C by 3 bar), 9, oval....
15" overall length, 5" handle....
15" overall length, 9" handle....
Medicine Products: